The Olympics is scrapping its controversial testosterone limits for trans and intersex athletes
- The IOC overturned its policy limiting the levels of testosterone athletes competing in women's sports can have.
- For years, intersex and trans athletes alike have said the policy unfairly targets and blocks them from competing.
The IOC released a six-page document on Tuesday detailing how the original 2015 policy will change.
"Every athlete has the right to practice sport without discrimination and in a way that respects their
In 2015, the IOC placed restrictions on trans women that required them to be on feminizing hormone treatments for two years and have a testosterone level that falls below 10nmol/L to compete. The testosterone limit was also applied to intersex athletes like South African Olympic gold medalist Caster Semenya, who was barred from running in her preferred event for years.
Moving forward, the IOC will adopt a more case by case approach to determine athletes' eligibility to compete at the games, rather than a blanket rule on hormones.
The announcement comes after years of advocates, scientists, and athletes alike advocated against the previous policies which barred many trans and intersex athletes from competing.
The previous restrictions were based on a deep misunderstanding of hormones, according to scientists and advocates
Previous IOC guidelines required trans and intersex women to undergo medical interventions to lower their natural levels of testosterone. Scientists and trans advocates say the guidelines were based on incorrect assumptions about the power of testosterone.
"What we see is they base their information on myths, misconceptions, and stereotypes about the trans community," Chris Mosier, an advocate and the first out trans member of Team USA, previously told Insider. "They're largely comparing trans women to cisgender men."
- SC slams Nupur Sharma, says her loose tongue set the country on fire
- Will review tax on crude, diesel and ATF every fortnight says Nirmala Sitharaman
- JB Pharma acquires four pediatric brands of Dr Reddy’s Labs for ₹98.3 crore
- Hyundai feels the pinch of chip shortage, global sales fall 4.5%
- Audi gets back some of its lost shine with EVs, gears up for launch